Hedge Fund - Kynikos

Four employees of Daniel Och’s Och-Ziff Capital Management Group (OZM) have left the hedge fund’s London office over the past week, two people with knowledge of the matter said.

The Madison Square Garden Company surprised many on Monday when it announced — besides exploring a potential breakup of itself — that it was adding two financiers to its board, one being the activist...

Usually, conferences, where some of the best investors voice their opinion about the markets, economy and even present some of their best stock picks, represent a great source of insights, especially ...

Hedge fund manager Jim Chanos on Monday said he is betting against Brazil's national oil company Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), saying it "exists to serve the state." Chanos, who first...

Steve Wynn, the billionaire casino mogul, has filed a lawsuit accusing prominent short-seller Jim Chanos of slander over an alleged statement that Wynn violated a U.S. anti-bribery law.

Hedge-fund manager James Chanos of Kynikos Associates describes how he became a “fundamental short seller” in this week's "Masters in Business" podcast. Listen to the full interview here.

In the latest round of 13F filings, Israel Englander's Millennium Management disclosed its equity positions as of the end of March.

Tiger Global Management LLC, the $14 billion investment firm run by Chase Coleman, increased its stakes in industrial companies last quarter and reduced holdings of technology firms.

Short-seller James Chanos said he’s betting against shares of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) -2.92% amid its unsolicited $46 billion bid for Allergan, Inc.